儿童头颈横纹肌肉瘤长期生存者中多个眼科危及器官的放射剂量-毒性关系探索
该国际横断面队列研究纳入38例原发儿童头颈横纹肌肉瘤长期生存者(≥2年随访),共评估74只眼,分析放疗剂量与眼科不良事件的关系。中位随访9年,结果显示眶、泪腺、晶状体平均剂量分别超过40、10、6 GyEQD2后,眼球移位、干眼、白内障(任何级别)概率>20%;视网膜和视神经最大剂量分别超过40和53 GyEQD2后才出现视网膜病变和视神经病变。这是首个基于临床评估的眼科不良事件描述的儿童多OAR剂量-毒性关系。
要点
- 眶平均剂量>40 GyEQD2后眼球移位概率>20%。
- 泪腺平均剂量>10 GyEQD2后干眼概率>20%。
- 晶状体平均剂量>6 GyEQD2后白内障(任何级别)概率>20%。
核心结论
- 首次描述儿童头颈横纹肌肉瘤长期生存者中多个眼科危及器官的特定剂量-毒性关系,基于临床评估的眼科不良事件。
研究设计与样本
- 国际横断面队列研究,纳入原发儿童头颈横纹肌肉瘤且随访≥2年的生存者,治疗包括光子外照射、质子束治疗或近距离放疗(近距离放疗均联合手术)。
- 共评估38例生存者的74只眼,中位随访9年,从原始放疗计划收集剂量学数据,OAR在3D放疗计划CT上勾画,剂量换算为2 Gy分次等效剂量(GyEQD2)。
主要发现
- 眶平均剂量>40 GyEQD2、泪腺平均剂量>10 GyEQD2、晶状体平均剂量>6 GyEQD2后,随访时眼球移位、干眼或白内障(任何级别)的概率>20%。
- 视网膜病变仅发生在视网膜最大剂量>40 GyEQD2后,视神经病变仅发生在视神经最大剂量>53 GyEQD2后。
关键数值与推荐
- 眶平均剂量>40 GyEQD2对应眼球移位概率>20%。
- 泪腺平均剂量>10 GyEQD2对应干眼概率>20%。
- 晶状体平均剂量>6 GyEQD2对应白内障(任何级别)概率>20%。
- 视网膜最大剂量>40 GyEQD2后出现视网膜病变。
- 视神经最大剂量>53 GyEQD2后出现视神经病变。
临床怎么用
- 可依据上述剂量-毒性关系量化并向患者告知预期临床毒性概率,帮助避免未来患者发生眼科不良事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Ophthalmological adverse events (OAE) are prevalent after local treatment for pediatric head and neck rhabdomyosarcoma (HNRMS). We examine the relation between radiation dose to multiple ophthalmological organs at risk (OAR) and associated clinical OAE in HNRMS survivors. METHODS: Clinical data on OAE were systematically assessed in an international cross-sectional cohort study including survivors of primary pediatric HNRMS with ≥ 2 years follow-up. Included survivors were treated with either external beam radiation therapy with photons (XRT) or protons (PBT), or with brachytherapy (BT). BT was always delivered in conjunction with surgery (AMORE strategy), whereas XRT and PBT were sometimes combined with surgery. Dosimetric data were collected from the original radiotherapy treatment plans. OAR were delineated on the 3D radiotherapy planning CT. Radiation dose was recalculated into the equivalent dose in 2 Gy fractions (GyEQD2). RESULTS: A total of 74 eyes in 38 survivors were assessed. Median follow-up time was 9 years. Following mean doses > 40, >10, and > 6 GyEQD2 to the orbit, lacrimal gland, and lens, respectively, survivors had a > 20% probability of globe displacement, dry eyes, or cataract (any grade) at follow-up. Retinopathy and optic neuropathy only occurred following maximum doses of > 40 and > 53 GyEQD2 to the retina and optic nerve, respectively. CONCLUSION: We offer the first description of specific dose-toxicity relationship for multiple OAR in children, based on clinically assessed OAE in long-term survivors. These results can help to quantify and inform physicians and future patients about expected probability of clinical toxicity and help to avoid OAE occurrence for future patients.
引用
- Morfouace M, Hol M, Schoot R, et al. Exploration of the radiation dose-toxicity relationship for multiple ophthalmological organs at risk for pediatric patients assessed in long-term head and neck rhabdomyosarcoma survivors. Clin Transl Radiat Oncol. 2026. PMID: 42404299. doi:10.1016/j.ctro.2026.101199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。